Name | Type | Posted | Actions |
|---|---|---|---|
Attachment G_Question Submittal Form_Clarifying Questions(Amend6).xlsx | XLSX | Mar 17, 2022 | |
FDA-22-SOL-1231488_Amend6.pdf | Mar 17, 2022 | ||
FDA-22-SOL-1231488_Amend5.pdf | Mar 16, 2022 | ||
Room Utilization from Attachment I.pdf | Mar 7, 2022 | ||
Sol_QR Part II TO1 SOW.xlsx | XLSX | Mar 7, 2022 | |
TASK ORDER 1 SOW_Amend1.pdf | Mar 7, 2022 | ||
FDA-22-SOL-1231488_Amend4.pdf | Mar 7, 2022 | ||
Part II Sol_QR.xlsx | XLSX | Feb 16, 2022 | |
FDA-22-SOL-1231488_Amend3.pdf | Feb 16, 2022 | ||
TASK ORDER 1 SOW AV Pogram Management and Planning.doc | DOC | Feb 3, 2022 | |
Sol_QR.xlsx | XLSX | Nov 4, 2021 | |
Attachment D_Amend1.xlsx | XLSX | Nov 4, 2021 | |
FDA-22-SOL-1231488_Amend2.pdf | Nov 4, 2021 | ||
FDA-22-SOL-1231488_Amend1.pdf | Nov 1, 2021 | ||
FDA-22-SOL-1231488.pdf | Oct 21, 2021 | ||
Attachment E_Standard Form LLL Disclosure of Lobbying Activities.pdf | Oct 21, 2021 | ||
Attachment B_FAR Deviation 18-01 (Whistleblower Protection-Commercial).pdf | Oct 21, 2021 | ||
Attachment C_ Wage Determinations.pdf | Oct 21, 2021 | ||
Attachment H_PPQ.docx | DOCX | Oct 21, 2021 | |
Attachment J_ Metropolitan Area Site List.xlsx | XLSX | Oct 21, 2021 | |
Attachment A_Virtual Meeting Support Services.docx | DOCX | Oct 21, 2021 | |
Attachment G_Question Submittal Form.xlsx | XLSX | Oct 21, 2021 | |
Attachment F_Labor Category Descriptions.docx | DOCX | Oct 21, 2021 | |
Attachment D_IDIQ Pricing Worksheet.xlsx | XLSX | Oct 21, 2021 | |
Attachment I_Technical Scenario.docx | DOCX | Oct 21, 2021 | |
Attachment K_FAR Deviation 2021-03 Ensuring Adequate COVID-19 Safety Protocols for Federal Contractors.pdf | Oct 21, 2021 |
Audio Visual Support, Design, Installation and Equipment/System Services
Audio Visual Support, Design, Installation and Equipment/System Services
Contact and place of performance
Maeve Xavier
Silver Spring, MD 20993
USA
Solicitation Amendment 6: The Government is not requesting proposals for Task Order 1. Submissions related to Task Order 1 will not be evaluated. See attachment "FDA-22-SOL-1231488_Amend6" for the following: Pricing requirements for the Technical Scenario were deleted and verbiage clarifying that pricing is only required for the IDIQ was added. The solicitation Part II due date IAW Amendment 5 remains the same. All r...
View moreThe Food and Drug Administration (FDA) has issued this request for proposal (RFP) for a broad range of technical and non-technical audio-visual (AV) and meeting room services to support physical and virtual workspaces. This requirement primarily serves the White Oak campus in Silver Spring, Maryland, which accommodates over 11,000 personnel and more than 250 shared meeting rooms. The scope encompasses program planning, public meeting support, system design and installation, and the maintenance or repair of AV equipment. Technical services involve leveraging advanced technologies such as streaming, webcasting, and integrated telecommunications—including Cisco WebEx and Video Teleconference equipment—to facilitate participation for teleworking personnel and reduce travel requirements.
The contractor is responsible for the full lifecycle of AV technology, including the procurement of software licenses, the installation of new systems, and the maintenance or upgrading of existing hardware. Non-technical support includes room configuration and light housekeeping for conferences and training sessions. Under this indefinite-delivery, indefinite-quantity (IDIQ) contract, service providers will manage the interface of AV equipment with data management and telephone systems while performing regular preventive maintenance. This solicitation is a competitive 8(a) small business set-aside. Classification is identified under NAICS 541513 Computer Facilities Management Services and PSC DA01 IT and Telecom - Business Application/Application Development Support Services (Labor).
Managed by the FDA Office of Acquisitions and Grants Services, this solicitation requires proposals to be submitted by March 25, 2022. Recent amendments clarified that pricing is only required for the IDIQ itself and not for Task Order 1, which will not be evaluated. Administrative updates through Amendment 6 also modified Factor 4 Management Approach requirements and corrected solicitation numbering. The record for this opportunity includes 26 attachments, including various solicitation amendments, question submittal forms, and room utilization data. Maeve Xavier is the designated point of contact for this requirement under solicitation number FDA-22-SOL-1231488.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.